Literature DB >> 15132378

Clinical and histopathological characteristics of uveal melanoma in Asian Indians. A study of 103 patients.

Jyotirmay Biswas1, Sachin Kabra, S Krishnakumar, Mahesh P Shanmugam.   

Abstract

PURPOSE: To study the clinical and histopathological characteristics of uveal melanomas in Asian Indians and compare them with other ethnic groups.
MATERIALS AND METHODS: One hundred and three enucleated eyes with clinical diagnosis of uveal melanoma were retrospectively studied (1987-2001) and the clinical and pathological features analysed.
RESULTS: Uveal melanomas constituted 0.02% of outpatients in a referral eye hospital in India over a 12-year period. The patients were predominantly males. Uveal melanomas tended to occur in the younger age. The mean age was 45.7 +/- 14.2 years. Melanoma involved the choroid in 90 (87.37%) patients, and both choroid and ciliary body in 13 (12.62%) patients. Mean basal diameter of the tumour was 13.43 +/- 5.32 mm. Mixed cell type was more common.
CONCLUSION: Uveal melanomas are rare in the Asian Indians compared to those in the West. They occur in younger persons, have a greater mean basal diameter than that of Caucasians and are predominantly of the mixed cell type.

Entities:  

Mesh:

Year:  2004        PMID: 15132378

Source DB:  PubMed          Journal:  Indian J Ophthalmol        ISSN: 0301-4738            Impact factor:   1.848


  12 in total

1.  Melanoma : A Frequently Missed Diagnosis.

Authors:  R Lakhtakia; A Mehta; S K Nema
Journal:  Med J Armed Forces India       Date:  2011-07-21

2.  Clinicopathologic characteristics of choroidal melanoma in a North Indian population: analysis of 10-year data.

Authors:  Seema Kashyap; Pradeep Venkatesh; Seema Sen; Sumeet Khanduja; Dinesh Shrey; Sana Tinwala; Satpal Garg
Journal:  Int Ophthalmol       Date:  2013-07-04       Impact factor: 2.031

Review 3.  Uveal melanoma: relatively rare but deadly cancer.

Authors:  S Kaliki; C L Shields
Journal:  Eye (Lond)       Date:  2016-12-02       Impact factor: 3.775

Review 4.  Prognosis of uveal melanoma based on race in 8100 patients: The 2015 Doyne Lecture.

Authors:  C L Shields; S Kaliki; M N Cohen; P W Shields; M Furuta; J A Shields
Journal:  Eye (Lond)       Date:  2015-08-07       Impact factor: 3.775

5.  Multifocal choroidal melanoma in oculodermal melanocytosis in an Asian Indian.

Authors:  Raksha Rao; Santosh G Honavar; Kaustubh Mulay
Journal:  Indian J Ophthalmol       Date:  2019-12       Impact factor: 1.848

6.  Evaluation of Racial, Ethnic, and Socioeconomic Associations With Treatment and Survival in Uveal Melanoma, 2004-2014.

Authors:  Nitya Rajeshuni; Talhah Zubair; Cassie A Ludwig; Darius M Moshfeghi; Prithvi Mruthyunjaya
Journal:  JAMA Ophthalmol       Date:  2020-08-01       Impact factor: 7.389

7.  Episcleral plaque brachytherapy using 'BARC I-125 Ocu-Prosta seeds' in the treatment of intraocular tumors: a single-institution experience in India.

Authors:  Parag K Shah; V Narendran; U Selvaraj; P Guhan; Sanjay K Saxena; Ashutosh Dash; Melvin Astrahan
Journal:  Indian J Ophthalmol       Date:  2012-07       Impact factor: 1.848

8.  Monosomy 3 by chromogenic in situ hybridization (CISH) in Iranian patients with uveal melanoma.

Authors:  Masood Naseripour; Mitra Mehrazma; Rama Pourmatin; Mohsen Bahmani Kashkouli; Ahad Sedaghat; Elmira Gheytanchi
Journal:  J Curr Ophthalmol       Date:  2015-11-04

Review 9.  Uveal Melanoma in Asians: A Review.

Authors:  Pradeep Manchegowda; Arun D Singh; Carol Shields; Swathi Kaliki; Parag Shah; Lingam Gopal; Pukhraj Rishi
Journal:  Ocul Oncol Pathol       Date:  2021-02-09

10.  Clinico-Pathological Association of Delineated miRNAs in Uveal Melanoma with Monosomy 3/Disomy 3 Chromosomal Aberrations.

Authors:  Nalini Venkatesan; Jagat Kanwar; Perinkulam Ravi Deepa; Vikas Khetan; Tamsyn M Crowley; Rajeswari Raguraman; Ganesan Sugneswari; Pukhraj Rishi; Viswanathan Natarajan; Jyotirmay Biswas; Subramanian Krishnakumar
Journal:  PLoS One       Date:  2016-01-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.